Journal articlesAderma™ dermal pads in the prevention of pressure ulcers

Aderma™ dermal pads in the prevention of pressure ulcers

01/11/12 | Pressure Ulcers, Products | Sylvia Woods

Pressure ulcers have a significant impact on both patients and health service budgets. Many pressure ulcers are avoidable through improved prevention. Aderma (Smith & Nephew) dermal pads are a simple, intuitive technology that can help contribute to the prevention of pressure ulcers. An evaluation of Aderma dermal pads was conducted across four wards in a single hospital in the UK. The incidence of hospital-acquired pressure ulcers following the introduction of Aderma was compared with the incidence prior to the introduction. The results show that there was a reduction of approximately 70% in the incidence of hospital-acquired pressure ulcers following the introduction of Aderma. The hospital estimates that this resulted in savings of approximately £140,000 in pressure ulcer treatment costs over a three-month period. The findings suggest that Aderma has the potential to contribute to reducing the incidence of pressure ulcers when integrated into pressure ulcer prevention protocols. Conflicts of interest: This evaluation was supported through a grant from Focus Product Developments. Aderma has since been acquired by Smith & Nephew and is now a registered trademark of Smith & Nephew.